You have no items in your shopping cart.
Product Details
| Alternate Name | 5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide |
|---|---|
| Appearance | Off-white to pale yellow solid |
| CAS # | 50-65-7 |
| Molecular Formula | C₁₃H₈Cl₂N₂O₄ |
| Molecular Weight | 327.12 |
| Purity | ≥98% by HPLC |
| Solubility | DMSO (10 mM) or Ethanol (25 mM) |
| SMILES | C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O |
| InChi | InChI=1S/C13H8Cl2N2O4/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15/h1-6,18H,(H,16,19) |
| InChi Key | RJMUSRYZPJIFPJ-UHFFFAOYSA-N |
| PubChem CID | 4477 |
| MDL Number | MFCD00057597 |
| Handling | Protect from air and light |
| Storage Conditions | -20°C |
| Shipping Conditions | Gel Pack |
| USAGE | For Research Use Only! Not For Use in Humans. |
Details
A STAT3 signaling pathway inhibitor. Niclosamide potently inhibits the activation and transcriptional function of STAT3 and induces cell growth inhibition, apoptosis, and cell cycle arrest of cancer cells with constitutively active STAT3. Also reversibly inhibits mTORC1 signaling and stimulates autophagy in vitro; displays antineoplastic effects in acute myelogenous leukemia (AML) stem cells. It is identified in drug screening studies to inhibit SARS-CoV in vitro, presumably by interfering with host-regulated pathways.
Why buy BioVision Products?
 |
 |
 |
 |
Innovation |
Affordability |
Global Presence |
Technical Support |
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways. |
BioVision is committed to providing the highest quality products at a competitive price. |
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery. |
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently. |
Zhao, Juan et al. (2016) Niclosamide suppresses renal cell carcinoma by inhibiting Wnt/β-catenin and inducing mitochondrial dysfunctions, Springerplus. 2016 Aug 30;5(1):1436.
For more citations of this product click here
